Complete remission of ovarian cancer induced intractable malignant ascites with intraperitoneal bevacizumab. Immunological observations and a literature review.

Investigational New Drugs
Filippo BellatiPierluigi Benedetti Panici

Abstract

Malignant ascites resistant to conventional drugs frequently affects ovarian cancer patients at the end of life. Here we report the case of a patient who benefited from complete resolution of ascites after low dose intraperitoneal administration of bevacizumab. Immunological analyses showed an initial increase in proportion and function of CD8(+) effector T cells and a reduction of circulating T(reg) cells. A review of the current literature regarding bevacizumab in ovarian cancer is reported. Bevacizumab has shown a high efficacy in the treatment of ovarian cancer. Intraperitoneal administration induces an immune activation and appears promising in the treatment of malignant ascites.

References

Jan 5, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J T TamsmaA E Meinders
Mar 18, 2004·Journal of the National Cancer Institute·Gordon J S RustinJan Vermorken
Jun 15, 2004·Journal of the American College of Surgeons·Rony A Adam, Yehuda G Adam
Aug 28, 2004·Annals of Nutrition & Metabolism·Florian J SchweigertUlrich Buscher
Feb 22, 2005·Gynecologic Oncology·Bradley J MonkRobert A Burger
Jun 18, 2005·Biochemical and Biophysical Research Communications·Napoleone FerraraWilliam Novotny
Jan 6, 2006·The New England Journal of Medicine·Deborah K ArmstrongUNKNOWN Gynecologic Oncology Group
Mar 11, 2006·Gynecologic Oncology·David E CohnJeffrey M Fowler
Mar 15, 2006·Gastroenterology Clinics of North America·Stefanie M Rosenberg
May 2, 2006·Gynecologic Oncology·Jason D WrightJanet S Rader
May 16, 2006·Gynecologic Oncology·Michael A BidusJohn C Elkas
Feb 15, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A A Ayantunde, S L Parsons
Mar 9, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·J P MichaJ V Brown
Jul 4, 2007·Journal of Pain and Symptom Management·Lisa J HerrintonSteven S Coughlin
Jul 13, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·N AroraR A Burger
Jul 25, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·J D WrightD G Mutch
Sep 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ruby F MeredithAlbert F LoBuglio
Nov 21, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert A BurgerJoel I Sorosky
Nov 21, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen A CannistraWilliam McGuire
Dec 22, 2007·Nature Reviews. Immunology·Laurence ZitvogelGuido Kroemer
Jan 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Agustin A GarciaAmit M Oza
Jan 15, 2008·Cancer Immunology, Immunotherapy : CII·Takuya OsadaMichael A Morse
Feb 22, 2008·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Aug 2, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nilofer S AzadElise C Kohn
Oct 16, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Axel GrotheyMark Kozloff
Nov 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Anne M SchultheisHeinz-Josef Lenz
Dec 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Seiji MabuchiMasahide Ohmichi
Feb 17, 2009·Journal of Experimental & Clinical Cancer Research : CR·Michael A StröhleinMarkus M Heiss
Jul 10, 2009·The Cochrane Database of Systematic Reviews·Anna Dorothea A D W WagnerSusanne Unverzagt

❮ Previous
Next ❯

Citations

Jul 1, 2011·Journal of Cancer·Marianna NutiAurelia Rughetti
Jan 12, 2012·Clinical & Developmental Immunology·Filippo BellatiMarianna Nuti
Dec 3, 2014·Seminars in Pediatric Surgery·Martijn W J StommelHarry van Goor
May 12, 2011·International Reviews of Immunology·Suzanne R Thibodeaux, Tyler J Curiel
Feb 5, 2013·Expert Opinion on Biological Therapy·Umberto Leone Roberti MaggioreSimone Ferrero
Nov 8, 2011·Critical Reviews in Oncology/hematology·Filippo BellatiMarianna Nuti
Mar 24, 2016·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Noraziah NordinNajihah Mohd Hashim
Dec 4, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G PassotE Cotte
Jan 28, 2014·Current Therapeutic Research, Clinical and Experimental·Jun YuQi Chen
Jan 28, 2015·Oral Oncology·Qiao LiJeffrey S Moyer
Aug 16, 2016·Asia-Pacific Journal of Clinical Oncology·Joanna Md JonesCatherine M Shannon
Sep 14, 2016·Oral Oncology·Chloé RancouleNicolas Magné
Dec 24, 2011·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·William R RobinsonPaiyarut Kanjanavaikoon
Feb 13, 2018·Apoptosis : an International Journal on Programmed Cell Death·Noraziah NordinNajihah Mohd Hashim
Feb 22, 2013·Nature Reviews. Cancer·Emma KippsStan B Kaye
May 9, 2015·World Journal of Gastroenterology : WJG·Aflah RoohullahLorraine Chantrill
Jan 1, 2016·Expert Review of Quality of Life in Cancer Care·Larissa MeyerGordon B Mills
Feb 23, 2021·The Journal of International Medical Research·Furong KouLin Shen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.